Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment
- PMID: 33995424
- PMCID: PMC8117210
- DOI: 10.3389/fimmu.2021.682195
Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment
Keywords: COVID-19; SARS-CoV-2; advanced therapies; exosomes; stem cells.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment.Front Immunol. 2020 Jul 3;11:1563. doi: 10.3389/fimmu.2020.01563. eCollection 2020. Front Immunol. 2020. PMID: 32719683 Free PMC article. Review.
References
-
- Schäfer R, Spohn G, Bechtel M, Bojkova D, Baer PC, Kuçi S, et al. Human Mesenchymal Stromal Cells are Resistant to SARS-CoV-2 Infection Under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells. Stem Cell Rep (2020) 16(3):419–27. 10.1016/j.stemcr.2020.09.003 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
